Cargando…

Effects of olmesartan on arterial stiffness in rats with chronic renal failure

BACKGROUND: It has been suggested that the antioxidant properties of olmesartan (OLM), an angiotensin II type 1 receptor (AT(1)R) blocker, contribute to renal protection rather than blood pressure lowering effects despite the fact that causal relationships between hypertension and renal artery disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuang, Yao-Chen, Wu, Ming-Shiou, Su, Yi-Kai, Fang, Kwang-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472279/ https://www.ncbi.nlm.nih.gov/pubmed/22694778 http://dx.doi.org/10.1186/1475-2840-11-66

Ejemplares similares

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
por: Takami, Takeshi, et al.
Publicado: (2013)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial [Corrigendum]
Publicado: (2013)

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study
por: Nishida, Yayoi, et al.
Publicado: (2011)

Impairment of myocardial functions and arterial stiffness in patients with lichen planus()()
por: Baykal Selcuk, Leyla, et al.
Publicado: (2020)

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study
por: Kereiakes, Dean J, et al.
Publicado: (2012)

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial
por: Sakata, Yasuhiko, et al.
Publicado: (2015)

Pulmonary Function and Arterial Stiffness in Chronic Heart Failure
por: Li, Li, et al.
Publicado: (2016)

Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus
por: Yiu, Kai-Hang, et al.
Publicado: (2013)

Association of female sex and heart rate with increased arterial stiffness in patients with type 2 diabetes mellitus
por: Kang, Min-Kyung, et al.
Publicado: (2017)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
por: Teixeira, Mónica, et al.
Publicado: (2019)

Evaluation of the ambulatory arterial stiffness index in lead-exposed workers
por: Karakulak, Uğur Nadir, et al.
Publicado: (2017)

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus
por: Yue, Wen-Sheng, et al.
Publicado: (2011)

Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort
por: Sung, Ki-Chul, et al.
Publicado: (2013)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial
por: Hughes, Timothy M, et al.
Publicado: (2012)

Association between triglyceride glucose index and arterial stiffness in Korean adults
por: Lee, Sang Bae, et al.
Publicado: (2018)

Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever
por: Çakar, Mustafa, et al.
Publicado: (2017)

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes
por: Katakami, Naoto, et al.
Publicado: (2020)

Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart
por: Markus, Marcello Ricardo Paulista, et al.
Publicado: (2019)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
por: Lee, Hsiang-Chun, et al.
Publicado: (2019)

Olmesartan: Induced maculopapular rash
por: Bhushan, Aruna, et al.
Publicado: (2013)

Enteropatía secundaria a olmesartán
por: Curieses Luengo, María, et al.
Publicado: (2017)

Association Between Statin Use and Progression of Arterial Stiffness Among Adults With High Atherosclerotic Risk
por: Zhou, Yan-Feng, et al.
Publicado: (2022)

Predictive values of coronary artery calcium and arterial stiffness for long‐term cardiovascular events in patients with stable coronary artery disease
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors
por: Phababpha, Suphawadee, et al.
Publicado: (2013)

Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study
por: Wu, Shouling, et al.
Publicado: (2021)

Pediatric stiff-person syndrome with renal failure
por: Kumar, M. Veerendra, et al.
Publicado: (2016)

Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
por: Omboni, Stefano, et al.
Publicado: (2018)

Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure
por: Alem, Manal M, et al.
Publicado: (2018)

Stiffness memory of EA.hy926 endothelial cells in response to chronic hyperglycemia
por: Targosz-Korecka, Marta, et al.
Publicado: (2013)

Arterial Stiffness and Cerebral Small Vessel Disease
por: Zhai, Fei-Fei, et al.
Publicado: (2018)

Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function
por: LU, XIAO-MEI, et al.
Publicado: (2014)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease
por: Tanındı, Aslı, et al.
Publicado: (2015)

Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes
por: Yoo, Hye Jin, et al.
Publicado: (2011)

Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes
por: Shin, Jin Young, et al.
Publicado: (2011)

Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance
por: Sciacqua, Angela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ljaovm4h2pohmfetjabrf4hii